Jostling among hospitals, pharmacies, doctors, and third-party payers over the delivery of specialty cancer drugs is likely to intensify, according to experts observing the already fast shifting field of oncology treatment channeling. Read More »
Approved for use with diet and exercise; also approved as a combination therapy with other diabetes medications and insulin. Read More »
Cancer vaccine WO-12 to be developed by Pfizer and Western Oncolytics. Read More »
Franchise partnership agreement signed with Emart last week. Read More »
First potential treatment for CLN2 on fast track for development. Read More »
Clear side Biomedical Inc. recently released the reports from its Phase II TANZANITE clinical trial showing top-line data from the study. Read More »
Cynosure recently announced that SculpSure has received marketing approval from the Korean Ministry of Food and Drug Safety (MFDS) for non-invasive lipolysis of the abdomen and flanks. Read More »
Arizona Oncology is championing SpaceOar hydrogel, a new tool that has proven to protect patients with prostate cancer from the adverse effects of radiation therapy. Read More »
he Office of the National Coordinator for Health Information Technology (ONC), run by the U.S. Department of Health and Human Services (HHS), made a joint announcement with the Assistant Secretary for Preparedness and Response (ASPR) establishing funding opportunities for an Information Sharing and Analysis Organization (ISAO) for both the health care and public health sectors. Read More »
Arizona Oncology recently broke ground during a ceremony celebrating its new cancer treatment center in East Valley. Read More »
Defense spending bill stalled in Congress; fifth filibuster in two years. Read More »
CVS Health has released naloxone, an opioid overdose-reversal medication, for sale without the need of a prescription in all CVS Pharmacy locations in Texas. Read More »
The Kroger Co. recently announced an agreement had been reached with Axium Pharmacy Holdings Inc. that will allow Kroger to acquire the outstanding shares of Modern HC Holdings Inc. (ModernHealth). Read More »
DexCom recently announced that the U.S. Food and Drug Administration’s (FDA) Clinical Chemistry and Clinical Toxicology Devices Panel has voted to approve the DexCom G5 Mobile CGM system’s proposed non-adjunctive indication. Read More »
Two high-cost arthritis medications — one the world’s best-selling drug — may soon make way for generic equivalents following preliminary committee approval, but the Food and Drug Administration must still decide whether the products are fully interchangeable. Read More »
.jpg)
Spark Therapeutics and Pfizer Inc. recently announced that SPK-9001 has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA). Read More »
Cigna has responded to the U.S. Department of Justice’s (DOJ) decision to challenge its merger with Anthem. Read More »
Ajanta Pharma USA Inc., an Ajanta Pharm Ltd subsidiary, recently announced that it has launched the generic form of Zegerid Capsules, called Omeprazole and Sodium Bicarbonate Capsules, in the United State Read More »
Ionis Pharmaceuticals, Inc. recently announced $10 million in earnings from Janssen Biotech Inc. after licensing the drug, INOIS-JBI1-2.5Rx, which is designed to hinder an undisclosed target in the gastrointestinal (GI) tract that is used to treat GI autoimmune disease. Read More »
Lannett Company, Inc. recently announced that an Acceptable for Filing letter has been issued to its strategic partner Sparsha Pharma USA, Inc. from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System. Read More »
Alerts Sign-up
